Search

Your search keyword '"Harding, James J."' showing total 16 results

Search Constraints

Start Over You searched for: Author "Harding, James J." Remove constraint Author: "Harding, James J." Publisher springer science and business media llc Remove constraint Publisher: springer science and business media llc
16 results on '"Harding, James J."'

Search Results

1. ASO Visual Abstract: Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma

2. Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma

4. Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers

5. Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS

7. Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancers

8. Characterization and phase I study of CLR457, an orally bioavailable pan-class I PI3-kinase inhibitor

9. A phase 1 study of ADI-PEG 20 and modified FOLFOX6 in patients with advanced hepatocellular carcinoma and other gastrointestinal malignancies

11. HER kinase inhibition in patients with HER2- and HER3-mutant cancers

12. Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

13. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

14. A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel

15. Patient perspectives on ipilimumab across the melanoma treatment trajectory

Catalog

Books, media, physical & digital resources